Search…

Hong Kong stock market anomaly | China Biotech (01177.HK) rose nearly 7% during trading. TQC3721's overseas equity amounting to a maximum of USD 1.9 billion has been authorized to AstraZeneca.

10/07/2026

According to the Securities Times app, China Biotech (01177.HK) rose nearly 7% again, accumulating a total increase of over 20% this month. As of the time of publication, it had risen by 4.8% to 5.24 Hong Kong dollars, with a trading volume of 6.97 billion Hong Kong dollars.

Latest

1 m ago

Chint Electric: Successfully bid for a controlling stake in a subsidiary with a 3.16% equity for 1.116 billion yuan.

1 m ago

Infineon raises product prices and warns of supply shortages.

2 m ago

Shanghai Futures Exchange: This week, copper inventory decreased by 22,406 tons, aluminum inventory decreased by 24,229 tons, zinc inventory increased by 952 tons, lead inventory increased by 858 tons, nickel inventory decreased by 2,525 tons, tin inventory decreased by 351 tons, and natural rubber inventory increased by 1,317 tons.

2 m ago

Radiation material investigation report contains hundreds of errors and the Japanese government claims it has no impact on health.

2 m ago

National Immigration Administration: In the first half of the year, immigration management agencies across the country inspected a total of 369 million inbound and outbound persons, an increase of 10.8% year-on-year, reaching a record high.

See all latest